Pfizer and Moderna said their updated vaccines, which target the XBB.1.5 subvariant of the virus, were expected to be available for most people in the United States in the coming days. The FDA approved those shots for people ages 12 and above, and authorized them for emergency use in children ages 6 months through 11 years.
Tag Archive for: Omicron variant
The European Medicines Agency (EMA) said on Wednesday its human medicines committee (CHMP) recommended authorizing Pfizer’s updated COVID-19 vaccine targeting the dominant XBB.1.5 variant of Omicron.
Canada has detected its first case of coronavirus infection from the highly mutated BA.2.86 variant of Omicron in a person in British Columbia who had not traveled outside the Pacific province, health officials said on Tuesday.
Swiss drugs regulator Swissmedic said on Wednesday it is examining potential risks in connection with bubbles that appeared in vials of COVID-19 vaccine boosters retooled to target the Omicron variant of the coronavirus.
GSK beat third-quarter earnings forecasts on Wednesday and raised its 2022 estimate for the second time in four months, continuing its strong start as a standalone prescription medicine business since spinning off its consumer health unit.
Starting next week, Americans will not be able to order free at-home COVID tests from a website set up by the U.S. government due to limited supply.
In a recent large-scale study, Pfizer’s Paxlovid (nirmatrelvir and ritonavir tablets) appeared to be far more effective at reducing deaths and hospitalizations in older adults than younger patients stricken with the Omicron variant of COVID-19.
The United Kingdom’s COVID booster campaign is set to kick off this September, after the country became the first in the world to approve an Omicron-adapted shot.
The European Medicines Agency (EMA) has started a rolling review of a variant-adapted COVID-19 vaccine from Pfizer and BioNTech, it said on Tuesday.
People at high risk of severe disease who have yet to get a second COVID-19 booster should not wait for next-generation, Omicron-targeted vaccines expected in the fall, five vaccine experts told Reuters.
